Search results
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 5 hours agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Moderna Stock Seesaws After The FDA Throws It A Curveball
Investor's Business Daily· 6 days agoThe FDA was due to make a decision by May 12. Moderna emphasized the FDA has not said it found any...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 2 days agoFurther, the companies are running a late-stage study in non-small cell lung cancer patients. One...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 4 days agoAnd, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 2 days agoBut news last week disappointed investors, who were expecting a regulatory decision on the RSV candidate by May 12. Moderna said the U.S. Food and Drug...
Stock Market News for May 14, 2024
Zacks via Yahoo Finance· 2 days agoMarket News Wall Street ended mixed on Monday as market participants sought insights...fell 0.2% or 81.33 points to close at 39,431.51. Notably, 13...
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 3 days agoFollowing the completion of the transaction, the director now owns 2,011,931 shares in the company, valued at approximately $244,811,764.08. On Wednesday, May 1st, Noubar Afeyan sold 15,000 ...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 6 days agoModerna Inc.’s stock fell 2.6% Friday, after the company said the Food and Drug Administration will...
Top Stock Movers Now: TSMC, Moderna, Sweetgreen, and More
Investopedia· 6 days agoU.S. equities were mixed at midday, as the markets reacted to corporate headlines and report showing...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall
Investing.com· 6 days agoModerna says FDA delaying decision on RSV vaccine approval, shares fall